Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful intravenous alteplase for acute ischemic stroke secondary to radiation-induced intracranial arterial stenosis in a child: An illustrative case.

Surgical neurology international·2026
Same author

A Semantic-Enhanced Multi-Source Fusion Localization Method for GNSS-Degraded Environments.

Sensors (Basel, Switzerland)·2026
Same author

Rural medical disparities in multimodal glioblastoma treatment.

Scientific reports·2026
Same author

Application-Dependent Early-Phase Stability of Autologous Fibrin Glue in Endoscopic Transsphenoidal Surgery.

World neurosurgery·2026
Same author

Surfer's Myelopathy with Magnetic Resonance Imaging Evidence Suggestive of Venous Congestion: A Case Report.

NMC case report journal·2026
Same author

A persistent craniopharyngeal canal harboring adenohypophyseal lineages associated with Rathke's cleft cyst: illustrative case.

Journal of neurosurgery. Case lessons·2026

Related Experiment Video

Updated: Jan 7, 2026

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

1.0K

Talaporfin Sodium as a Clinically Translatable Radiosensitizer in Radiodynamic Therapy.

Junko Takahashi1, Junkoh Yamamoto2, Kohei Suzuki2

  • 1Graduate School of Information, Production and Systems, Waseda University, Kitakyusyu, Fukuoka 808-0135, Japan.

Biomolecules
|December 30, 2025
PubMed
Summary

Talaporfin sodium, used in photodynamic therapy (PDT), shows promise in radiodynamic therapy (RDT) for deep-seated cancers. It generates reactive oxygen species with X-rays, significantly inhibiting pancreatic tumor growth in mice.

Keywords:
RNA-seqmono-L-aspartyl chlorin e6 (NPe6)pancreatic cancerphotodynamic therapy (PDT)radiodynamic therapy (RDT)radiotherapytalaporfin sodium

More Related Videos

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:40

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

941
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

8.0K

Related Experiment Videos

Last Updated: Jan 7, 2026

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

1.0K
Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:40

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

941
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

8.0K

Area of Science:

  • Oncology
  • Radiotherapy
  • Photodynamic Therapy

Background:

  • Talaporfin sodium (NPe6) is a second-generation photosensitizer used in photodynamic therapy (PDT).
  • While effective, treating deep-seated tumors with PDT remains challenging.
  • Talaporfin sodium exhibits favorable pharmacokinetics, including tumor selectivity and rapid clearance.

Purpose of the Study:

  • To investigate talaporfin sodium's potential as a radiosensitizer in radiodynamic therapy (RDT).
  • To evaluate the efficacy of talaporfin-mediated RDT against pancreatic cancer xenografts.
  • To explore the underlying mechanisms of talaporfin-mediated RDT.

Main Methods:

  • Talaporfin sodium was administered intravenously to a pancreatic cancer xenograft mouse model (MIA PaCa-2 cells).
  • Mice received fractionated X-ray irradiation (3 Gy daily for 3 days) after talaporfin sodium administration.
  • Tumor growth inhibition was assessed, and RNA sequencing was performed on xenografts.

Main Results:

  • Talaporfin-mediated RDT significantly inhibited tumor growth compared to radiation therapy alone.
  • RNA-seq analysis revealed transcriptional signatures indicative of oxidative stress and immune activation in tumors.
  • Talaporfin sodium generates reactive oxygen species upon interaction with X-rays, similar to 5-ALA in RDT.

Conclusions:

  • Talaporfin sodium acts as an effective radiosensitizer for RDT, enhancing tumor cell killing through oxidative and immunogenic mechanisms.
  • Talaporfin-mediated RDT presents a promising therapeutic strategy for deep-seated malignancies, including pancreatic cancer.
  • This approach offers a clinically translatable option for enhancing radiotherapy outcomes.